A critique of clinical equipoise therapeutic misconception in the ethics of clinical trials

Hastings Center Report

Volumn 33, Issue 3, 2003, Pages 19-28

  Miller, Franklin G ^a   Brody, Howard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL APPROACH; ARTICLE; BENEFICENCE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; CONFLICT OF INTEREST; CONTROLLED CLINICAL TRIAL; ECONOMICS; ETHICS; FINANCIAL MANAGEMENT; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; MORALITY; RANDOMIZED CONTROLLED TRIAL; RESEARCH ETHICS; UNCERTAINTY;

ANALYTICAL APPROACH; BIOMEDICAL AND BEHAVIORAL RESEARCH;

BENEFICENCE; CONFLICT OF INTEREST; DISCLOSURE; ETHICS, MEDICAL; ETHICS, RESEARCH; FINANCIAL SUPPORT; HUMANS; INFORMED CONSENT; MORAL OBLIGATIONS; RANDOMIZED CONTROLLED TRIALS; RESEARCH SUPPORT; THERAPEUTIC HUMAN EXPERIMENTATION; UNCERTAINTY;

EID: 0141797654     PISSN: 00930334     EISSN: 1552146X     Source Type: Journal    
DOI: 10.2307/3528434     Document Type: Review

References (43)

1. Hypericum Depression Trial Study Group, "Effect of Hypericum Perforatum (St John's Wort) in Major Depressive Disorder: a Randomized Controlled Trial,"JAMA (2002):1807-1814.
2. Ibid., 1813.
3. S.M. Stahl, Essential Psychopharmacology of Depression and Bipolar Disorder (New York: Cambridge University Press, 2000).
4. P.S. Appelbaum, L.H. Roth, C.W. Lidz, P Benson, and W. Winslade, "False Hopes and Best Data: Consent to Research and the Therapeutic Misconception," Hastings Center Report 17, no. 2 (1987):20-24.
5. P.S. Appelbaum, "Clarifying the Ethics of Clinical Research: a Path Toward Avoiding the Therapeutic Misconception," American Journal of Bioethics 2, no. 2 (2002):22.
6. B. Freedman, "Placebo-Controlled Trials and the Logic of Clinical Purpose," IRB 12, no. 6 (1990): 1-6.
7. R.J. Levine, "Clarifying the Concepts of Research Ethics," Hastings Center Report 9, no. 3 (1979):21-26.
8. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report (Washington, D.C.: U.S. Government Printing Office, 1979) p. 3.
9. E.J. Emanuel, D. Wendler, and C. Grady, "What Makes Clinical Research Ethical?" JAMA 283 (2000) 2701-2711.
10. J. Sugarman, N.E.Kass, S.N. Goodman, P. Perentesis, P. Fernandes, and R.R.Faden, "What Patients Say About Medical Research," IRB 20, no. 4 (1998):1-7.
11. F.G. Miller, D.L.Rosenstein, and E.G. DeRenzo, "Professional Integrity in Clinical Research," JAMA 280 (1998):l449-54.
12. R.R.Faden and T.L.Beauchamp, A History and Theory of Informed Consent (New York: Oxford University Press, 1986):200-232.
13. D.A. Braunholtz, S.J.L.Edwards, and R.J. Lilford, "Are Randomized Clinical Trials Good For Us (in the Short term)? Evidence for a "Trial Effect," Journal of Clinical Epidemiology 54 (2001):217-224.
14. J.W Berg, P.S. Appelbaum, C.W.Lidz, and L.S. Parker, Informed Consent: Legal Theory and Clinical Practice, 2nd edition (New York: Oxford University Press, 2001):280-283.
15. R.J. Levine, Ethics and Regulation of Clinical Research, 2nd ed. (New Haven: Yale University Press, 1986):8-10.
16. J. Katz, "Ethics and clinical research" revisited: a tribute to Henry K. Beecher," Hastings Center Report 23, no. 5 (1993):36.
17. C. Fried, Medical Experimentation: Personal Integrity and Social Policy (New York: American Elsevier, 1974).
18. Ibid., 5
19. Ibid., 94.
20. A.B.Hill, "Medical ethics and controlled trials," British Medical Journal 1 (1963): 1043-1049.
21. C. Fried, Medical Experimentation: Personal Integrity and Social Policy (New York: American Elsevier, 1974): 8.
22. D. Marquis, "Leaving therapy to chance," Hastings Center Report 13, no. 4 (1983):40-47.
23. Ibid., 40.
24. F. Gifford, "The Conflict Between Randomized Clinical Trials and the Therapeutic Obligation, Journal of Medicine and Philosophy 11 (1986):347-366.
25. B. Freedman, "Equipoise and the Ethics of Clinical Research," NEJM 317 (1987):141-145.
26. Ibid., 144.
27. B. Freedman, "Placebo-Controlled Trials and the Logic of Scientific Purpose," IRB 12, no. 6 (1990):5.
28. T.L. Beauchamp, and J.F. Childress, Principles of Biomedical Ethics 5 th edition (New York: Oxford University Press, 2001):323-327.
29. B. Freedman, K.C. Glass, and C. Weijer, "Placebo Orthodoxy in Clinical Research. II: Ethical, Legal and Regulatory Myths," Journal of Law, Medicine &h Ethics 24 (1996):252-259.
30. R. Temple and S. E. Ellenberg, "Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments: Part 1: Ethical and Scientific Issues, Annals of Internal Medicine 133 (2000):455-63.
31. TP. Laughren, "The Scientific and Ethical Basis for Placebo-Controlled Trials in Depression and Schizophrenia: an FDA Perspective, European Psychiatry 16 (2001):418-423.
32. Department of Health and Human Services. Protection of Human Subjects. Code of Federal Regulations. 45CFR46, 1991.
33. K.J. Rothman and K.B. Michels, "The Continuing Unethical Use of Placebo Controls," NEJM 331 (1994):394-8.
34. See B. Freedman, K.C. Glass, and C. Weijer, "Placebo Orthodoxy in Clinical Research. I: Empirical and Methodological Myths, Journal of Law, Medicine & Ethics 24 (1996):243-51; and B. Freedman, K.C. Glass, and C.Weijer, "Placebo Orthodoxy in Clinical Research. II: Ethical, Legal and Regulatory Myths, Journal of Law, Medicine & Ethics 24 (1996):252-259.
35. R. Temple and S.E. Ellenberg, "Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments: Parr 1: Ethical and Scientific Issues," Annals of Internal Medicine 133 (2000):455-63
36. E.J.Emanuel and EG. Miller, "The Ethics of Placebo-Controlled Trials-a Middle Ground, NEJM345 (2001):915-919.
37. S.Hellman and D.S. Hellman, "Of Mice But Not Men: Problems of the Randomized Controlled Trial, NEJM 324 (1991):1585-1589.
38. EG, Miller and H. Brody, "What Makes Placebo-Controlled Trials Unethical? American Journal of Bioethics 2, no. 2 (2002):3-9.
39. N. Dickert and C. Grady, "What's the Price of a Research Subject? Approaches to Payment for Research Participation, New England Journal of Medicine 341 (1999): 198-203.
40. See E.J.Emanuel, D. Wendler, and C. Grady, "What Makes Clinical Research Ethical? JAMA 283 (2000):2701-2711.
41. B. Freedman, K.C. Glass, and C.Weijer, "Placebo Orthodoxy in Clinical Research. II: Ethical, Legal and Regulatory Myths, Journal of Law, Medicine & Ethics 24 (1996):253.
42. R. Temple and S.E, "Placebo-Controlled Trials and Active-Control trials in the Evaluation of New Tteatments: Part 1: Ethical and Scientific Issues, Annals of Internal Medicine 133 (2000):455-63.
43. C. Weijer, "When Argument Fails, American Journal of Bioethics 2, no. 2 (2002): 10.